Zhejiang CONBA Pharmaceutical Co Ltd
SSE:600572

Watchlist Manager
Zhejiang CONBA Pharmaceutical Co Ltd Logo
Zhejiang CONBA Pharmaceutical Co Ltd
SSE:600572
Watchlist
Price: 4.78 CNY Market Closed
Market Cap: 11.9B CNY
Have any thoughts about
Zhejiang CONBA Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Zhejiang CONBA Pharmaceutical Co Ltd

Wall Street analysts forecast Zhejiang CONBA Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 6.46 CNY with a low forecast of 5.45 CNY and a high forecast of 7.63 CNY.

Lowest
Price Target
5.45 CNY
14% Upside
Average
Price Target
6.46 CNY
35% Upside
Highest
Price Target
7.63 CNY
60% Upside
Zhejiang CONBA Pharmaceutical Co Ltd Competitors:
Price Targets
3613
Beijing Tong Ren Tang Chinese Medicine Co Ltd
45% Upside
600535
Tasly Pharmaceutical Group Co Ltd
20% Upside
OGI
OrganiGram Holdings Inc
71% Upside
300725
PharmaBlock Sciences Nanjing Inc
13% Upside
IPN
Ipsen SA
22% Upside
FUM
Futura Medical PLC
333% Upside

Revenue
Forecast

Revenue Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 12%.

3%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is -3%. The projected CAGR for the next 3 years is 12%.

-3%
Past Growth
12%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Zhejiang CONBA Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is 4%. The projected CAGR for the next 3 years is 16%.

4%
Past Growth
16%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Zhejiang CONBA Pharmaceutical Co Ltd's stock price target?
Price Target
6.46 CNY

According to Wall Street analysts, the average 1-year price target for Zhejiang CONBA Pharmaceutical Co Ltd is 6.46 CNY with a low forecast of 5.45 CNY and a high forecast of 7.63 CNY.

What is Zhejiang CONBA Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's revenue is 3%. The projected CAGR for the next 3 years is 12%.

What is Zhejiang CONBA Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's operating income is -3%. The projected CAGR for the next 3 years is 12%.

What is Zhejiang CONBA Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Zhejiang CONBA Pharmaceutical Co Ltd's net income is 4%. The projected CAGR for the next 3 years is 16%.

Back to Top